Clinical Trial Update: CDK4/6 Inhibitors Intensification for Chemotherapy Omission in Small Size High-risk ER-positive Breast Cancer（Cinnamon） [Phase 3]

View source ↗

Summary

A Phase 3 study called Cinnamon is evaluating whether intensifying treatment with CDK4/6 inhibitors can omit chemotherapy in small-sized, high-risk ER-positive …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CDK4/6 inhibitors

Snippet

Sponsor: Fudan University | Conditions: Breast Cancer | Phase 3 | Status: NOT_YET_RECRUITING